Major hepatic resection may suppress the growth of tumours remaining in the residual liver

British Journal of Cancer

Volumn 83, Issue 8, 2000, Pages 1096-1101

  Yokoyama, H ^a,b   Goto, S ^a,b   Chen, C L ^a   Pan, T L ^a   Kawano, K ^b   Kitano, S ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Apoptosis; HCC; Hepatectomy; Rat; Tumour growth

Indexed keywords

FAS ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; GENE EXPRESSION; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VOLUME;

EID: 0033770282     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1379     Document Type: Article

References (34)

1. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model
2. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver
3. Hepatectomy prolongs survival of mice with induced liver metastases
4. The effect of partial hepatectomy on tumor growth in rats: In vivo and in vitro studies
5. Partial hepatectomy augments the liver's antitumor response
6. Recurrent form of hepatocellular carcinoma after partial hepatic resection
7. Regulation of apoptosis-associated genes in the regenerating liver
8. Spontaneous acceptance of rat liver allografts is associated with an early downregulation of intragraft interleukin-4 messenger RNA expression
9. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
10. Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression
11. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues
12. Experimental pathology of the liver; restoration of the liver of the white rat following partial surgical removal
13. A variant mRNA species encoding a truncated form of Fas antigen in the rat liver
14. Long-term results after resection of hepatocellular carcinoma: Experience of 480 cases
15. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1
16. Promotion of hepatic metastases by liver resection in the rat
17. Postoperative recurrence of hepatocellular carcinoma
18. Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression
19. Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
20. The Fas and Fas ligand pathways in liver allograft tolerance
21. Dysregulation of apoptosis as a mechanism of liver disease: An overview
22. Partial hepatectomy accelerates local tumor growth: Potential roles of local cytokine activation
23. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma
24. Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha
25. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion?
26. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
27. Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma
28. Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway
29. In vivo response of hepatocytes to growth factors requires an initial priming stimulus
30. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways
31. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
32. Recurrence of hepatocellular carcinoma after surgery
33. A reproducible rat liver cancer model for experimental therapy: Introducing a technique of intrahepatic tumor implantation
34. Development of a rat model for orthotopic liver transplantation for hepatocellular carcinoma